Skip to main content
Sánchez-Fernández, I., Cuevas, P., Angulo, J., López-Navajas, P., Canales-Mayordomo, A., González-Corrochano, R., Lozano, R.M., Valverde, S., Jiménez-Barbero, J., Romero, A. and Giménez-Gallego G
[2010]. Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors. J. Biol. Chem. 285, 11714-11729
Lozano, R.M., Pérez-Maceda, B.T., Iglesias, C., Rubio, J.C., Clemente, C., Carboneras, M., del Valle, J.A., García-Alonso, M.C., and Escudero, M.L
[2009]. Degradación de biomateriales reabsorbibles de base Mg en cultivos celulares de osteoblastos e in vivo”. Actas del XXVII Congreso Anual de la Sociedad Española de Ingeniería Biomédica. 39-41
Canales-Mayordomo, A., Lozano, R.M., López-Méndez, B., Angulo, J., Ojeda, R., Nieto, P., Martín-Lomas, M., Giménez-Gallego, G. and Jiménez-Barbero, J.
[2006]. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. FEBS J. 273, 4716-4727
Canales-Mayordomo, A., Fayos, R., Angulo, J., Ojeda, R. Martín-Pastor, M., Nieto, P.M., Martín-Lomas, M., Lozano, R., Giménez-Gallego, G and Jiménez-Barbero, J.
[2006]. Backbone dynamics of a biolocally active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods. J. Biomol. NMR 35, 225-239
Cuevas, P., Díaz-González, D., Sánchez, I., Lozano, R.M., Giménez-Gallego, G and Dujovny, M.
[2006]. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells. Neurol. Res. 28, 127-130
Cuevas, P., Díaz-González, D.,García-Martín-Córdova, C., Sánchez, I., Lozano, R.M., Giménez-Gallego, G and Dujovny, M.
[2006]. Dobesilate diminishes activation of the mitogen-activated protein kinase ERK1/2 in glioma cells. J. Cell. Mol. Med. 10, 237-242
Canales, A., Angulo, J., Ojeda, R., Bruix, M., Lozano, R.M., Giménez-Gallego, G., Martín-Lomas, M., Nieto, P.M. and Jiménez-Barbero, J.
[2005]. Conformational Flexibility of a Synthetic Glycosylaminoglycan Bound to a Fibroblast Growth Factor. FGF-1 Recognizes both the 1C4 and 2SO Conformations of a Bioactive Heparin-like Hexasaccharide. JACS 127, 5778-5779
Fernández-Tornero, C*. Lozano, R.M.*, Rivas, G., Jiménez, M. A., Ständker, L., Díaz-González, D., Forssmann, W-G., Cuevas, P., Romero, A. and Giménez-Gallego, G.
[2005]. Synthesis of the blood circulating C terminal fragment of IGF-binding protein-4 in its native conformation: Crystallization, heparin and IGF binding, osteogenic activity. J. Biol. Chem. 280, 18899-18907
Angulo, J., Ojeda, R., de Paz, J.L., Lucas, R., Nieto, P. M., Lozano, R.M., Redondo-Horcajo, M., Giménez-Gallego, G. and Martín-Lomas, M.
[2004]. The activation of fibroblasts growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1. Chembiochem. 5, 55-61
Fernández-Tornero, C.*, Lozano, R.M.*, Redondo-Horcajo, M., Gómez, A. M., López, J.C., Quesada, E., Uriel, C., Valverde, S., Cuevas, P., Antonio Romero, A. and Giménez-Gallego, G.
[2003]. Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5‑amino-2‑naphthalenesulfonate. J. Biol. Chem. 278, 21774-21781
de Paz, J.L., Angulo, J., Lassaletta, J.M., Nieto, P.M., Redondo-Horcajo, M, Lozano, R.M., Giménez-Gallego, G and Martín-Lomas, M.
[2001]. The activation of fibroblast growth factor by heparin: Synthesis, structure and biological activity of heparin-like oligosaccharides. Chembiochem 2, 673-685. (2001)
Cuevas, P., Carceller, F., Díaz, D., Reimers, D., Fernández, M., Lozano, R.M. and Giménez-Gallego, G.
[2001]. Abolished angiogenicity and tumorigenicity of rat glioma by 1-naphthalenesulfonate. Neurosci. Lett. 308, 185-188.
Lozano, R.M.*, Redondo-Horcajo, M.*, Jiménez, M.A., Zilberberg, L., Cuevas, P., Bikfalvi, A., Rico, M. and Giménez-Gallego, G.
[2001]. Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-Kda human platelet factor-4 fragment with antiangiogenic activity. J. Biol. Chem. 246, 35723-3573435
Hagedorn, M., Zilberberg, L., Lozano, R.M., Cuevas, P., Canron, X., Redondo-Horcajo, M., Giménez-Gallego, G. and Bikfalvi, A.
[2001]. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. Faseb J. 15, 550-552
Lozano, R.M., Pineda-Lucena, A., González, C., Jiménez, M.A., Cuevas, P., Redondo-Horcajo, M., Sanz, J., Rico, M. y Giménez-Gallego, G
[2000]. 1H-NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. Biochemistry 39, 4982-4993
